First case of imported African tick-bite fever in Poland - Case report Tomasiewicz, Krzysztof; Krzowska-Firych, Joanna; Bielec, Dariusz ...
AAEM. Annals of Agricultural and Environmental Medicine/Annals of Agricultural and Environmental Medicine,
01/2015, Letnik:
22, Številka:
3
Journal Article
Recenzirano
Odprti dostop
This is the first report of a case of African tick bite fever (ATBF) imported to Poland from South-Africa. The patient presented with fever of 38.4(o)C, generalized maculopapular rash and single ...eschar. Diagnosis was confirmed by polymerase chain reaction (PCR) from eschar biopsies. The patient recovered without any sequelae after 7 days treatment with doxycycline.
Fosfomycin is an old antibiotic with a unique chemical structure and with broadspectrum activity against numerous bacterial pathogens, both Gram-positive and Gramnegative, including resistant and ...multi-resistant strains. This antibiotic was accepted into clinical practice in the early 1970s. Its use, however, has been limited for several years for treating mainly lower uncomplicated urinary tract infections (in the form of fosfomycin trometamol taken orally). Nowadays, many clinicians and scientists are looking at this antibacterial drug for its employment in the treatment of severe infections caused by multi-resistant bacteria. Fosfomycin as an intravenous formulation (fosfomycin disodium) achieves clinically relevant concentrations in the serum and the cerebrospinal fluid, in kidney, bladder wall, prostate, lungs, bone and heart valves tissues, as well as in inflamed tissues and abscess fluid. The available clinical studies confirmed the efficacy of intravenous fosfomycin for the management of severe infections caused by multiresistant pathogens.
TTV virus (TTV) was first isolated in 1997 from the patient with acute post-transfusion hepatitis. This fact led to the conclusion that the virus was hepatotropic and could be one of the causative ...agents of acute hepatitis. Afterwards,however, the virus was found in other human tissues and serological studies revealed that it was widespread. Multiple tropisms of Trv and the fact of its high incidence in general population are considered to indicate no medical significance of Trv in human pathology. Here we present a report of two cases of TTV infection in patients who developed pancreas cancer. The patients were hospitalized at the Department of Infectious Diseases due to hepatitis of unknown origin. Since serological and virological markers of common primary and secondary hepatotropic viruses were negative, TTV-DNA was found in serum and was believed to be the only causative agent with probable hepatotropic action. The patients later developed pancreas cancer and they underwent operation. The relationship is difficult to confirm, however the cases we present should be treated as a preliminary report and a comment on the real role of TTV in human pathology.
: Patients with hematological malignancies have experienced a more severe clinical course of COVID-19 and higher mortality than those with solid tumors and those without cancer. The ongoing pandemic ...poses many challenges in assuring the correct and timely diagnosis of hemato-oncology patients as well as the optimal treatment.
: The present paper reviews current data on the incidence and clinical course of COVID-19 in patients with hematological malignancies. A literature review of the MEDLINE database for articles was conducted via PubMed. Publications from December 2019 through September 2020 were scrutinized. The search terms used were
OR
in conjunction with
OR
OR
OR
OR
. Recommendations and expert opinions either published or presented on ASH, ASCO, ESMO, NCCN websites were also reviewed.
: The COVID-19 pandemic has brought a pressing need to improve the management of patients with hematological malignancies, including establishing prompt diagnoses and providing effective treatment while also minimalizing the risk of SARS-Cov2 infection. The recommendations developed by many organizations based on expert opinions are helpful in making proper decisions. All cancer patients should be advised to get vaccinated against influenza and pneumococcus.